Informations techniques
Exploitant
NOVARTIS PHARMA S.A.
Présentation
LENTARON 250 mg, lyophilisat et solution pour usage parentéral Boîte de 2
eNq1mF1v2jAUhu/5FVHuSVL6QToFqo21G1KrMVq0aTfIJCfFLNjpsQ10v36GUJVOjsoMvoM4ec+xz/HjV06uVvPCWwAKylnHPwki3wOW8oyyx44/erhpxv5Vt5HMyILsvNYOouCk5XtpQYTo+OvRYAKEieDn3e1n0N8D+t2Gl/DJDFL55j0laRF8JWJ6R8r1O16y4DTz5iCnPOv4pZKbp14iJOosukuOv0VJUkjC7ZPd0dn4bPd5Eq7F9lBVAvCWsEejaI5WmqlCBCZ7RMIjx2ezdDpuxe2LKIqtQlAxBMEVpjAgcjpAvqAZZOZIpBBgFSRfZveAiwLkOohRPJylc2ElTmZkNYSnvjnpj3q0J1eyGTVP2hft+DxuRW39wyoU7iyVuXn0JMKyxGzcuowvovNWmGNY6BIS5KyZc5yDkISBZakGHCUpHBWJit7bdnMUB+Hp3WbIqCgL8hzMRGm7VASJHgbUUHA3kfUMHlBjqtBr9o8+U0UR/mfWoy1EHGW8ZlSPKyZrWHIztF2IHmcSVvUVtcOfXG17kYI4nuwfzszoH6hJQVNbwmkGKb27R8N+PeAcsuETETBCd3D4QVnGl+L40NktsqPsyw03jaLl+DQ6jy9P7Q/9X7qdag6fa4W8hFCziIpDENNnOT8ULrpDzVIv/emqNTfGiKekgBpr1LTEju7JFyfnrOvd7ahqwCj65frBtlu+K8Dn+81fozTNOrt1tsOyC9br9nwv92oXdw7bsZXIHo76LD61Wx6FZtJMpSzFhzCcEtEURC9hoDfZvofC1VEmr2n7Wjt3Xt+JGajMUQVbR6lPqiN0/+rZ7tL3rMKh9nf7/dZmG2NIVHBAHSqgO8Nu//r4JH/1vs7SHryBi7swG59KJOXMlWFSEzOCDz07dGnZjUab/JbntOYGprY1k7C6/ek2knB989Nt/AWIOg2c
N4G04E0x2JQJ11cp